Foothill Ventures

Coreshell Technologies, Inc. is a Berkeley, California-based company founded in 2017, specializing in the development of advanced lithium-ion batteries through innovative materials engineering. The company addresses critical degradation issues in rechargeable batteries with its proprietary nanolayer thin-film coating technology. This technology protects battery electrodes from harmful chemical reactions that can diminish capacity and safety, ultimately enhancing battery performance and durability. Coreshell's solutions are designed to integrate seamlessly into existing manufacturing processes, making significant improvements in battery capacity, safety, and cost-effectiveness for electric vehicle and grid storage markets. By focusing on these advancements, Coreshell aims to facilitate the transition to electric transportation and renewable energy.

NovoLINC is a technology company specializing in thermal interface solutions. It designs and manufactures advanced materials using a unique nanostructured system and proprietary process, aiming to improve heat management in high-performance applications within the automotive and aerospace industries.

Coreshell Technologies, Inc. is a Berkeley, California-based company founded in 2017, specializing in the development of advanced lithium-ion batteries through innovative materials engineering. The company addresses critical degradation issues in rechargeable batteries with its proprietary nanolayer thin-film coating technology. This technology protects battery electrodes from harmful chemical reactions that can diminish capacity and safety, ultimately enhancing battery performance and durability. Coreshell's solutions are designed to integrate seamlessly into existing manufacturing processes, making significant improvements in battery capacity, safety, and cost-effectiveness for electric vehicle and grid storage markets. By focusing on these advancements, Coreshell aims to facilitate the transition to electric transportation and renewable energy.

Coreshell Technologies, Inc. is a Berkeley, California-based company founded in 2017, specializing in the development of advanced lithium-ion batteries through innovative materials engineering. The company addresses critical degradation issues in rechargeable batteries with its proprietary nanolayer thin-film coating technology. This technology protects battery electrodes from harmful chemical reactions that can diminish capacity and safety, ultimately enhancing battery performance and durability. Coreshell's solutions are designed to integrate seamlessly into existing manufacturing processes, making significant improvements in battery capacity, safety, and cost-effectiveness for electric vehicle and grid storage markets. By focusing on these advancements, Coreshell aims to facilitate the transition to electric transportation and renewable energy.

ProteoWise Inc. is a biotechnology company based in Branford, Connecticut, established in 2018. It specializes in the development of 3-dimensional nanoscale protein capturing materials and proteomics instruments that enhance the efficiency and ease of protein analysis. The company’s innovative technology simplifies traditional western blot techniques, offering high information content, high throughput, and cost-effective solutions for researchers. Founded by a team of experienced scientists from the Strittmatter Lab at Yale University, ProteoWise aims to facilitate advancements in proteomics by providing tools that enable high-throughput bench-top applications, thereby supporting the ongoing genomic revolution.

Quantapore Inc. is a biotechnology company based in Menlo Park, California, founded in 2009 by Sascha C. Dennstedt and Martin Huber. The company specializes in developing an innovative nanopore-based nucleic acid sequencing technology that utilizes an optical readout mechanism. This approach differentiates Quantapore from traditional nanopore methods by offering lower costs and higher throughput through quantum-optic interactions between optically labeled nanopores and nucleic acid samples. This technology enables rapid and sensitive single-molecule sequencing of entire genomes, significantly advancing the capabilities of genomic analysis and providing valuable tools for medical professionals to enhance human health.